| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 02/15/2001 | WO2001010865A1 p38MAP KINASE INHIBITORS |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010844A1 φ-AMINO-α-HYDROXYCARBOXYLIC ACID DERIVATIVES HAVING INTEGRIN αvβ3 ANTAGONISM |
| 02/15/2001 | WO2001010841A2 Fluorene derivatives as integrin inhibitors |
| 02/15/2001 | WO2001010831A1 Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists |
| 02/15/2001 | WO2001010823A1 Carboxylic acid amides, their production and their use as drugs |
| 02/15/2001 | WO2001010816A2 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 02/15/2001 | WO2001010813A1 Crystals of the sodium salt of pravastatin |
| 02/15/2001 | WO2001010441A1 Torsemide polymorphs |
| 02/15/2001 | WO2001010421A1 Drug releasing biodegradable fiber implant |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000068264A3 A peptide inhibitor of fibrinogen blood clotting |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | DE19937350A1 Treating C1q-esterase inhibitor protein synthesis disorders, especially angioneurotic edema, using tibolone, without androgenic and virilization side-effects |
| 02/15/2001 | DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin |
| 02/15/2001 | DE19936521A1 Substituierte Pyrrolidin-2,3,4-trion-3-oxim-Derivate Substituted pyrrolidine-2,3,4-trione-3-oxime Derivatives |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381215A1 P38map kinase inhibitors |
| 02/15/2001 | CA2380981A1 Fluorene derivatives |
| 02/15/2001 | CA2380973A1 Substituted pyrrolidine-2-3,4-trione 3-oxime derivatives which are active as nmda receptor antagonists |
| 02/15/2001 | CA2380633A1 Peptide antagonists of factor viia |
| 02/15/2001 | CA2379977A1 Novel integrin receptor antagonists |
| 02/15/2001 | CA2379335A1 Crystals of the sodium salt of pravastatin |
| 02/15/2001 | CA2379322A1 Torsemide polymorphs |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/14/2001 | EP1076089A1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 02/14/2001 | EP1075839A1 Plasma expander, blood diluent and cryoprotector produced using amylopectin-potato starch |
| 02/14/2001 | EP1075530A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 02/14/2001 | EP1075528A1 Endothelin-converting-enzyme like protein |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075266A1 Hematopoietic stimulation |
| 02/14/2001 | EP0949946A4 Biological fluid processing |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 02/14/2001 | CN1284063A Compounds |
| 02/14/2001 | CN1284059A Biphenylamidine derivatives |
| 02/14/2001 | CN1283693A Cell factor CKLF-HIA with functions of hematopoietic stimulation and immunoregulation and its variant CKLF-HIB |
| 02/14/2001 | CN1283503A Oral liquid of gingko |
| 02/14/2001 | CN1283463A Process for preparing solid-state-microspherical vascular suppository of sodium alginate |
| 02/14/2001 | CN1283460A Application of respiratory chain buiquinone depressant in preventing thrombolytic reperfusion damage |
| 02/14/2001 | CN1061887C Medicine for improving hemotopoitic function |
| 02/14/2001 | CN1061883C Medicine for removing thrombus and promoting blood circulation |
| 02/14/2001 | CN1061846C Traditional chinese medicine for tonifying kidney, reinforcing spleen and mourishing blood and its prepn process |
| 02/13/2001 | US6187767 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 02/13/2001 | US6187564 Nucleotide sequences coding a fusion protein; for the proliferation, differentiation and activation of hematopoietic stem cells; for treatment of cancers; anticarcinogenic agents |
| 02/13/2001 | US6187562 Polynucleotides encoding human sphingosine Lyase |
| 02/13/2001 | CA2180977C Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 02/13/2001 | CA2067224C Hirudin/polyalkylene glycol conjugates |
| 02/13/2001 | CA2048619C Use of bactericidal/permeability increasing protein or biologically active analogs thereof to treat lipopolysaccharide associated gram negative infections |
| 02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
| 02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
| 02/08/2001 | WO2001055118A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient |
| 02/08/2001 | WO2001009609A2 Hepatitis c viral antigen immunoassay detection systems |
| 02/08/2001 | WO2001009558A1 Methods and apparatus for producing phase change ice particulate saline slurries |
| 02/08/2001 | WO2001009293A2 Mammalian adhesion protease peptides |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009159A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | WO2001009138A2 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | WO2001009121A2 2-pyrazolin-5-ones_as tyrosine kinase inhibitors |
| 02/08/2001 | WO2001009106A1 Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors |
| 02/08/2001 | WO2001009093A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | WO2001008679A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/08/2001 | WO2001008669A2 Therapeutic agents for lymphoedema |
| 02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
| 02/08/2001 | WO2000069855A3 Furanone derivatives as inhibitors of cathepsin s |
| 02/08/2001 | WO2000067769A8 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents |
| 02/08/2001 | WO2000064485A8 Specifically targeted catalytic antagonists and uses thereof |
| 02/08/2001 | WO2000063230A3 49 human secreted proteins |
| 02/08/2001 | WO2000058295A3 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/08/2001 | WO2000056737A3 Calanolides for inhibiting btk |
| 02/08/2001 | DE19937394A1 Fluorenderivate Fluoro derivatives |
| 02/08/2001 | DE19937219A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Ionenaustauscherchromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by ion-exchange chromatography |
| 02/08/2001 | DE19937218A1 Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie A process for the purification of the blood clotting factor VII-activating protease, its pro-enzyme or a mixture of both proteins by affinity chromatography |
| 02/08/2001 | CA2391267A1 Chemokine receptor antagonists and methods of use therefor |
| 02/08/2001 | CA2381945A1 Mammalian adhesion protease peptides |
| 02/08/2001 | CA2381004A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 02/08/2001 | CA2380644A1 2-pyrazolin-5-ones |
| 02/08/2001 | CA2380029A1 Benzenamine derivatives as anti-coagulants |
| 02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2376245A1 Binding moieties for fibrin |
| 02/08/2001 | CA2345753A1 A method to increase the excretion of non-sterol endogenous hydrophobic substances by increasing excretion of fat via the faeces |
| 02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
| 02/07/2001 | EP1074631A2 Compounds having glucuronic acid derivatives and glucosamine derivatives in the structure, process for producing the same and utilization thereof |
| 02/07/2001 | EP1074616A1 Process for purification of the factor VII-activating protease, its proenzyme or a mixture of both proteins, by ion-exchange chromatography |
| 02/07/2001 | EP1074615A1 Methods for purification of Factor VII activating Protease, its proenzyme or a mixture of both forms, by affinity chromatography |
| 02/07/2001 | EP1074245A2 Composition using mineral salts for therapeutic treatment |
| 02/07/2001 | EP1073758A1 Retroviral vectors including modified envelope escort proteins |
| 02/07/2001 | EP1073634A1 Method for producing enantiomer-free n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide |
| 02/07/2001 | EP1073453A1 Methods to increase white blood cell survival after chemotherapy |
| 02/07/2001 | EP1073449A1 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors |
| 02/07/2001 | EP0462207B1 T-pa mutants resistant to inhibition by their cognate inhibitors |
| 02/07/2001 | CN1283231A Moldified vitamin K-dependent polypeptides |
| 02/07/2001 | CN1283186A Indole derivatives as XA factor inhibitors |
| 02/07/2001 | CN1283184A Process for stereo selective synthesis of prostacyclin derivatives |